The doctrine of equivalents in the medtech arena
The role of the doctrine of equivalents in assessing the value of, and risks associated with, medtech patents is often overlooked. Christopher Bright and Nathan Smith of Morgan Lewis report.
- The plausibility battleground at the EPO 09-11-2020
- A stricter interpretation: the EPO and antibodies 27-10-2020
- COVID-19: Protection of IP for AI tools 01-09-2020
- Why Santen ends Neurim-style SPCs 25-08-2020
- The right recipe for the repurposing omelette 14-08-2020
Latest news
Philips defeats antitrust claims in ultrasound infringement suit
24-11-2020
Philips was not anti-competitive when it refused a medical equipment maintenance company access to its software for ultrasound machines but did misuse its copyright, the US District Court for the Western District of Washington has ruled.
